Mst out and HCC in
Bin Zhao1, Qunying Lei, Kun-Liang Guan
1Department of Pharmacology and Moores Cancer Center, University of California at San Diego, La Jolla, CA 92093-0815, USA.
Abstract:
Mst1 and Mst2 are key components of the Hippo tumor suppressor pathway. In this issue, Zhou et al. (2009) reported that Mst1/2 ablation leads to hepatocellular carcinomas. Unexpectedly, Mst1/2 may activate another kinase besides Lats1 and Lats2 to phosphorylate YAP, and the role of Mst1/2 in YAP regulation is cell type dependent.
Insights
Mst1 and Mst2 proteins are crucial for the Hippo pathway. Their removal causes liver cancer and affects YAP phosphorylation in a cell-specific manner.
Area of Science:
- Cell biology
- Oncology
- Molecular signaling
Background:
- Mammalian STE20-like kinases 1 and 2 (Mst1/2) are integral components of the Hippo tumor suppressor pathway.
- The Hippo pathway regulates organ size and suppresses tumor formation.
Purpose of the Study:
- To investigate the role of Mst1/2 in liver cancer development.
- To explore the mechanisms by which Mst1/2 regulate the Yes-associated protein (YAP).
Main Methods:
- Analysis of Mst1/2 ablation in mouse models.
- Investigating kinase activity and protein phosphorylation.
- Assessing YAP regulation in different cell types.
Main Results:
- Mst1/2 ablation resulted in hepatocellular carcinomas.
- Mst1/2 were found to activate kinases that phosphorylate YAP, beyond Lats1/2.
- The regulatory role of Mst1/2 in YAP phosphorylation is cell type-dependent.
Conclusions:
- Mst1/2 are essential tumor suppressors in the liver.
- Mst1/2 signaling pathway has implications for YAP regulation and cancer.
- Further research is needed to elucidate the cell-type-specific functions of Mst1/2 in YAP regulation.
Related Concept Videos
Multipotency of Hematopoietic Stem Cells
Cardiomyopathy III: Hypertrophic Cardiomyopathy

